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abstRact
Background and Aims: Patients undergoing restorative proctocolectomy have often suffered 
from active ulcerative colitis which should be remembered when assessing quality of life 
after operation. the aim of this study was to explore health-related quality of life after 
restorative proctocolectomy in those with poor or good pouch function and to compare 
that to patients with active or inactive ulcerative colitis and to the general population.
Material and Methods: altogether, 282 restorative proctocolectomy patients were 
investigated. the control group comprised 408 ulcerative colitis patients from the local 
register. Generic 15d and disease-specific inflammatory bowel disease questionnaire 
health-related quality of life instruments were used. Population-based data were available 
for 15d. Pouch function was evaluated with Öresland score and colitis activity with simple 
clinical colitis activity index.
Results: 15d results showed that patients with good pouch function had health-related 
quality of life similar to that of the general population. Health-related quality of life with 
inflammatory bowel disease questionnaire was equally good in patients with good pouch 
function (n = 131; 70%) and inactive colitis (n = 95; 63%), and equally impaired in patients 
with poor pouch function (n = 56; 30%) and active colitis (n = 18; 12%).
Conclusion: the majority of patients had health-related quality of life comparable to that 
in general population. most patients with active ulcerative colitis are likely to improve 
their health-related quality of life after successful surgery. these findings are important 
when informing colitis patients about life after surgery.
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Fig. 1. Flow chart of the formation of the study and the control 
group.
InTrODUCTIOn
restorative proctocolectomy (rPC) is the standard 
operation for patients with active ulcerative colitis 
(UC) (1). With successful surgery, patients can avoid a 
permanent stoma and are able to live a normal life. 
Health-related quality of life (HrQoL) is essential in 
evaluating the long-term results of the operation, since 
rPC may be associated with complications and func-
tional failures (2, 3).
Many studies have shown that HrQoL in rPC 
patients has been comparable to that in general popu-
lation (4–6). On the other hand, poor functional results 
are associated with impaired quality of life (7–9), 
which again may influence these patients’ daily lives. 
It must be noted that patients undergoing rPC usually 
suffer from active colitis and HrQoL after the opera-
tion is important in this group.
Here, we compared results separately to non-oper-
ated colitis patients with active or inactive disease and 
similarly in rPC patients with good or poor functional 
result. This information about functional outcome and 
quality of life is valuable when the physician is dis-
cussing surgical treatment with the patient.
MATErIAL AnD METHODS
PATIEnT SELECTIOn
This cross-sectional study included all consecutive 352 
patients with UC who underwent rPC at the Tampere 
University Hospital between 1985 and 2009; the sub-
jects were identified in the hospital records using the 
International Classification of Diseases, 9th revision 
(ICD-9) and International Classification of Diseases, 
10th revision (ICD-10) codes for UC and official codes 
for the operations performed. A database to form an 
rPC registry was collected from patient files including 
details on patient history, operation technique, postop-
erative morbidity, and follow-up. Of these, 282 had 
their pouch in function and could be located and they 
were sent questionnaires. Data were collected between 
October 2012 and May 2013. The control group con-
sisted of 408 age- and sex-matched UC patients from 
the local inflammatory bowel disease (IBD) register. It is 
a prospective register for all adult patients with IBD. 
Cases were collected retrospectively before 1986 and 
after that prospectively. The age and gender distribu-
tions of the study group and the control group were 
similar. See the selection path for the groups in Fig. 1. 
The clinical data of the study patients are retrieved from 
these registries mentioned above.
QUESTIOnnAIrES
The questionnaires were sent by mail, and one reminder 
was sent to the non-respondents. Two different instru-
ments were used to measure HrQoL; one generic (15D) 
and one disease specific (inflammatory bowel disease 
questionnaire (IBDQ)). Pouch function was assessed by 
Öresland score (10) and disease activity in non-operated 
subjects with UC by simple clinical colitis activity index 
(SCCAI) (11). The 15D instrument is Finnish, and the 
other questionnaires were translated from English into 
Finnish by official translators and a back-translation into 
English was done to confirm the linguistic accuracy of 
the translation.
The 15D is a generic self-administered measure of 
HrQoL. The instrument can be used both as a profile 
and as a single score measure. The questionnaire 
includes 15 dimensions: mobility, vision, hearing, 
breathing, sleeping, eating, speech, excretion, usual 
activities, mental function, discomfort and symptoms, 
depression, distress, vitality, and sexual activity. For 
each dimension, respondents choose one of the five 
ordinal levels best describing their current state of 
health. The valuation system is based on an applica-
tion of multi-attribute utility theory. The single-index 
score (15D score), reflecting overall HrQoL on a 0–1 
scale (1 = full health, 0 = being dead) and similarly, the 
dimension level values, reflecting the goodness of the 
levels relative to no problems on the dimension = 1 
and to being dead = 0, were calculated from the ques-
tionnaire using a set of population-based preference 
or utility weights. Mean dimension level values were 
used to draw 15D profiles. A difference of ≥0.03 in 15D 
score was considered clinically important in the sense 
that a person can, on average, feel the difference (18). 
The 15D has been used with IBD patients before (12). 
The 15D data for general population came from the 
national Health 2011 Survey representing Finnish 
population aged 18 and above. This sample (n = 4763) 
was weighted to reflect the age and gender distribu-
tion of the patients (13).
A disease-specific IBDQ is a widely used standard-
ized 32-item questionnaire, which addresses four differ-
ent aspects of life: digestive symptoms, social functioning, 
emotional status, and systemic symptoms. The question-
naire has been validated in patients undergoing rPC for 
UC (14). It has been translated into Finnish and used in 
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IBD (15). Total IBDQ score ranges from 32 to 224, a higher 
score indicating better quality of life.
Pouch function was assessed by Öresland score 
(10). It includes items about the number of day-
time and night-time bowel movements, inconti-
nence for liquid or solid stools, pad usage, urgency, 
diet, medication, and social handicap; these ratings 
are summarized into a single score (range, 0–15; 15 
being worst). The questionnaire was translated into 
Finnish and was used with the permission of the 
developer (10). This questionnaire has been tailored 
for rPC and used in previous studies to elicit pouch 
function and HrQoL in UC. In the study by 
Berndtsson et al., poor Öresland scores correlated 
negatively with HrQoL results (7). The authors 
classified the score indicating very good 0–4, good 
5–7, or poor pouch function 8–15. We decided to 
combine the groups with very good and good 
pouch function and hence the limit was set at a 
score of 8.
Disease activity of UC was measured using the 
SCCAI (11). A score of ≤2 was defined as remission, 
3–4 as mild or moderately active disease, and ≥5 as 
severely active disease (16, 17).
STATISTICS
The data were analyzed using SPSS (IBM Corp, 
released 2012. IBM SPSS Statistics for Windows, ver-
sion 21.0; IBM Corp, Armonk, nY).
The 15D index was chosen to be the main parame-
ter with which the power calculations were made in 
the planning phase. With 15D difference ≥0.03 can be 
detected by an individual (18). Power calculations 
have been made using PS program difference being 
0.03, power 80%, and statistical difference 0.05. In this 
way, both groups need to include 142 patients.
For categorical variables, the results are given as 
frequencies and percentages and for continuous vari-
ables as means and standard deviation or as medians. 
Comparisons between different patient groups were 
tested with chi-square test and in IBDQ scores with 
Kruskal–Wallis test. Independent samples t-test was 
used to compare the mean 15D scores of the patients 
and the age- and gender-standardized sample of 
general population. P-values ≤ 0.05 were considered 
statistically significant.
rESULTS
The gender distribution of the respondents was 47% 
of women in the study and 46% in the control group. 
The median age was 53 years in the study group and 
55 years in the control group. The demographic data 
on both groups for responders and non-responders 
are shown in Table 1.
rPC PATIEnTS
Of the 352 patients operated on between 1985 and 
2009, pouch failure (pouch excision or permanent ile-
ostomy without excision) had occurred in 42 and 
were excluded, 3 could not be reached and 25 had 
died (Fig. 1). Of the eligible 282 patients, 187 (66.3%) 
returned the questionnaires; 87 (67%, n = 130) of the 
women and 100 (66%, n = 152) of the men. The median 
age of the patients was 53 (range, 23–81) years, and 
the median follow-up time after rPC was 13 (range, 
4–28) years.
The 95 rPC patients who did not return the ques-
tionnaire were on average three and a half years 
younger than those who did respond; there was no 
gender difference between respondents and non-
respondents. When we compared the clinical data 
concerning the operation, we found that there was no 
significant difference in leakage or pelvic sepsis 
between the respondents and non-respondents.
Altogether, 131 (70%) of the patients had a well-
functioning pouch with a score of <8, and 56 (30%) 
had a poor pouch function.
UC PATIEnTS
In non-operated UC patients, 153 (37.5%) of 408 
returned the questionnaire. Seventy-one (46%) of them 
were women and 82 (54%) men. The median age of the 
patients was 55 (range, 24–81) years. Of the non-oper-
ated UC patients 95 (62.1%) were in remission, 39 
(25.5%) had mild to moderately active disease, and 18 
(11.8%) severely active, as defined by SCCAI.
TABLE 1












 ≤2 3–4 ≥5
non-operated patients 153 71 (46) 55 (24–81) 20 (6–48) 95 (62) 39 (25) 18 (12)





Öresland score, n (%)
<8 ≥8
rPC patients 187 87 (47) 53 (23–81) 13 (4–28) 131 (70) 56 (30)
non-respondents 95 43 (45) 48 (24–89) 12 (3–27)  
SCCAI: simple clinical colitis activity index; rPC: restorative proctocolectomy.
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15D SCOrES
The mean 15D score of the rPC patients undergoing 
surgery was lower (0.891 (0.097)) than that of general 
population (0.928 (0.077); p < 0.001). The rPC patients 
scored statistically significantly lower on 8 of the 15 
dimensions compared to the age- and gender- 
standardized sample of general population: sleeping, 
usual activities, excretion, discomfort and symptoms, 
depression, distress, vitality, and sexual activity (Fig. 
2A). In rPC patients with well-functioning pouches, 
the only significantly decreased score was in excre-
tion (Fig. 2B).
IBDQ SCOrES
Fig. 2A shows that HrQoL was equally good in 
patients with good pouch function and inactive UC 
when measured by disease-specific IBDQ and also 
equally impaired in those with poor pouch function 
and active UC.
The IBDQ subscores for the different groups are 
presented in Table 2.
Patients with good pouch function showed better 
results in all subscores than those with active colitis 
(p < 0.001). There was no difference between groups 
when divided by the indication for surgery (p = 0.135–
0.850).
The IBDQ scores for subgroups of different indica-
tions for patients undergoing surgery compared to UC 
of different disease activity are shown in Fig. 3B. Fig. 
3C shows the IBDQ scores of operated patients with 
different time from operation.
There was no difference in HrQoL after surgery in 
different indications or time from operation. The 
scores were lower for rPC patients for any indication 
for surgery or time from operation than UC patients in 
remission but higher than UC patients with active dis-
ease.
DISCUSSIOn
This study investigated HrQoL using generic (15D) 
and disease-specific (IBDQ) questionnaires in a large 
cohort of patients operated on at a single institution 
within a period spanning over two decades. The main 
finding of this study was that rPC patients with a 
well-functioning pouch achieved HrQoL similar to 
that in general population and UC patients with their 
disease in remission or mild to moderate activity.
HrQoL has previously been reported to improve 
after rPC and reach the level of that in general pop-
ulation (4–6), although the results are inconsistent 
(19, 20). In a recent Finnish multicentre study HrQoL 
was impaired compared to the general population. 
This study also aimed to identify factors for poor 
outcome and found older age at time of operation 
and preoperative hypertension to be significant pre-
dictors (21). In this study, most (n = 131,70.1%) of the 
rPC patients had well-functioning pouch. Well-
functioning pouch was associated with good 
HrQoL, and therefore, the majority of rPC patients 
were satisfied with their lives after surgery. Poor 
functional results of the pouch have been associated 
with low HrQoL (7–9, 22). This was also shown in 
this study. This is something about which we can 
inform the patients preoperatively even though we 
do not know the reliable risk factors to identify 
patients prone to poor pouch function or pouch fail-
ure before surgery (23, 24).
UC patients with only mildly active disease or the 
disease in remission reported quality of life equally as 
good as that of rPC patients with well-functioning 
pouch. The quality of life scores were equally poor in 
patients with poorly functioning pouch or severely 
active UC. An Italian study showed similar results: 
UC in remission showed an overall QoL similar to that 
of uncomplicated rPC patients, while the same two 
groups of patients with mild clinical activity had an 
overall QoL score similar to those of patients with 
complicated rPC (25). A recent study also showed that 
even though rPC patients reported higher bowel 
movement frequency than patients treated with anti-
TnF (tumor necrosis factor), the rPC patients reported 
better outcomes for general HrQoL (26).
The patients who are considered for operative treat-
ment are those with active acute severe colitis or med-
ically refractory disease or those with dysplasia or 
cancer. There was no difference in HrQoL when com-
paring study patients divided by indication. But, as 
we can see in Fig. 3B, patients in remission undergo-
ing surgery due to dysplasia or cancer were likely to 
experience deterioration in HrQoL, whereas patients 
operated on for active disease experience an improve-
ment in HrQoL after successful surgery. For dysplasia 
patients, we should emphasize the fact that with sur-
gical treatment potentially life-threatening disease 
Fig. 2. (2A) 15D scores of all restorative proctocolectomy patients 
with ileal pouch (n = 187) compared to general population 
n = 4762 and (2B) scores for well-functioning pouches (n = 131) in 
comparison to the population.
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will be treated, and yet, one can in most cases perform 
ileal pouch surgery with moderately good and stable 
HrQoL without permanent ileostomy.
The long-term results are important, since most of 
the patients undergoing surgery are young; the median 
follow-up time of 13 (range, 4–28) years in this study 
TABLE 2
IBDQ scores and subscores of patients undergoing surgery for different indications, pouch function groups, and control colitis patients for different 
disease activity groups.
Mean scores (MD) Total score Bowel disorder Emotional function Systemic symptoms Social function
Patients undergoing surgery
Indication
 Acute colitis (n = 79) 170.3 (36.8) 5.3 (1.0) 5.4 (1.3) 5.1 (1.3) 5.7 (1.4)
 Medically refractory (n = 93) 165.9 (35.7) 5.0 (1.1) 5.3 (1.2) 4.6 (1.3) 5.9 (1.2)
 Cancer or risk of cancer (n = 15) 172.3 (33.3) 5.3 (0.7) 5.3 (1.4) 4.8 (1.1) 6.4 (0.7)
Pouch function
 Good, score <8 (n = 131) 181.7 (27.1) 5.6 (0.7) 5.6 (1.0) 5.1 (1.1) 6.3 (0.9)
 Poor, score ≥8 (n = 56) 136.1(34.2) 4.2 (1.0) 4.2 (1.2) 3.8 (1.2) 4.9 (1.5)
Colitis patients not undergoing surgery
 UC in remission (n = 95) 199.3 (16.8) 6.3 (0.6) 6.2 (0.6) 5.7 (0.8) 6.8 (0.4)
 UC mildly active (n = 39) 173.4 (25.0) 5.4 (0.8) 5.4 (1.0) 4.7 (1.1) 6.2 (0.8)
 Active UC (n = 18) 133.7 (38.3) 4.1 (1.3) 4.1 (1.2) 3.7 (1.3) 4.6 (1.6)
UC: ulcerative colitis.
Fig. 3. IBDQ total scores in different subgroups of patients with ileal pouch or ulcerative colitis (UC) compared to non-operated patients 
for different disease activity groups. The score limits for each subgroup have been described in the Methods section; pouch function was 
measured by Öresland score and the activity of colitis by SCCAI score. (A) IBDQ total scores for good and poor functioning pouches. (B) 
IBDQ total scores in different subgroups of indication for surgery. (C) IBDQ total scores on subgroups on how much time had passed 
since operation.
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gives a good perspective on this. Quality of life was not 
dependent on the time elapsing since the operation.
A limitation of this study was the large number of 
patients who did not return the questionnaires. 
response rates have declined in Finland in recent dec-
ades both in men and women in all age groups, faster 
among men and in younger age groups (27). The non-
response rate was high especially in non-operated UC. 
nevertheless, it was possible make comparisons 
between patients with active and inactive UC, as we 
had enough patients in each activity group. 
Furthermore, there was no gender difference between 
operated and non-operated colitis patients, and the 
median age was almost the same. For comparison, in 
the entire colitis register, 45% were women, that is, the 
same percentage as in this study. The non-responders 
in rPC group were 3 years younger than the respond-
ers. Although younger patients have had slightly bet-
ter functional results, we assume that this small 
difference did not influence the results significantly. 
Pelvic inflammatory complications may impair the 
functional outcome (28, 29). The respondents and non-
respondents did not differ in leakage or pelvic sepsis. 
Therefore, we assume that the functional result that we 
used on dividing the rPC groups was valid. We did 
not investigate rPC patients who had experienced 
pouch failure. It would have not been possible to study 
the HrQoL before and after the pouch failure, which 
we think would have given the full picture. We did not 
include the patients undergoing permanent ileostomy. 
The number of such patients was low, including mostly 
elderly patients with a poor sphincter function and do 
not have rPC as an option. We did not have individual 
information about pre- and postoperative HrQoL. 
However, the results of our study show the same trend 
as studies with preoperative HrQoL data of how 
HrQoL improves after surgery (4, 6).
In conclusion, this study showed that successful 
rPC surgery for UC affords the majority of patients 
good and stable functional results. This again enables 
good long-term HrQoL, being comparable to that in 
the general population and in UC patients in remis-
sion. In the case of poor pouch function, quality of 
life remains at the same level to that in active UC. On 
the other hand, the surgery removes the disease-car-
rying colon, eliminating several risks, such as bleed-
ing or cancer development, and in most patients, 
burdensome and expensive medications can be dis-
continued. nevertheless, our results are important 
when counseling the patients before the operation.
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